Lonza, Bio*One Capital to build 2nd biopharmaceuticals making plant Channel NewsAsia
SINGAPORE: Swiss chemicals firm Lonza and Singapore's Bio*One Capital have announced a new joint venture. They are investing up to US$350 million in a second large-scale manufacturing facility in Singapore.
Swiss life science officials meet with FAU to discuss possible projects Sun-Sentinel
A life science delegation from Basel, Switzerland, moved north from its Coconut Grove base on Tuesday, meeting with administrators and top faculty members from Florida Atlantic University and touring the Scripps Florida research institute on FAU's Jupiter campus.
Art Basel brings Swiss biotech executives to South Florida Miami Herald
Like the conversations at dozens of art soirees this week, the chatter among the European dignitaries gathered at a posh Coral Gables hotel centered around Basel, Switzerland.
Swiss biotech leaders visit Florida BizJournals
A 16-member delegation of Swiss life sciences and biotechnology leaders has arrived for the third annual Basel/Miami CEO Forum.
Lonza, Bio*One invest $350 mln in 2nd Singapore plant Reuters via Yahoo! Asia News
SINGAPORE, Dec 5 (Reuters) - Swiss specialty chemicals firm Lonza and Singapore's Bio*One Capital announced plans on Tuesday to invest up to $350 million in a second plant in Singapore, the biggest investment in the country's biomedical sector this year.
Swiss takeover board clears Carlton takeover offer for Moevenpick Sharewatch
In November Carlton announced a public tender offer for all outstanding Moevenpick shares with a view to de-listing the company from SWX Swiss Exchange.
05-12-2006: Lonza, Bio*One invest RM1.25b in 2nd Singapore plant The Edge Daily
Swiss specialty chemicals firm Lonza and Singapore's Bio*One Capital announced plans on Dec 5 to invest up to US$350 million (RM1.25 billion) in a second plant in Singapore, the biggest investment in the country's biomedical sector this year.
Swiss economy to show more modest growth next year as US, Eurozone slow - UBS The Forex Market
ZURICH (AFX) - The Swiss economy is likely to slow to a more moderate pace in 2007, after an exceptionally good year in 2006, due mainly to the more muted economic outlook in the US and the Eurozone, economists at UBS believe.
More Top Stories Business Insurance
ZURICH, Switzerland—The latest Sigma study from Swiss Reinsurance Co. is predicting rapid growth in the market for insurance linked securities risk, such as catastrophe bonds.
Swiss economy to show more modest growth next year as US, Eurozone slow - UBS Sharewatch
According to UBS Wealth Management\'s latest research study, weaker exports and a deceleration in capital spending will probably cause growth to decelerate.
swiss+capital: swiss+capital